Clinical Trial Update: 2-cohort Study of Adult Patients With Severe Hemophilia A in Greece

View source ↗

Summary

A completed clinical trial update on a two-cohort study in adults with severe Hemophilia A conducted in Greece, sponsored by Bayer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: Bayer | Conditions: Hemophilia A | Status: COMPLETED